By Nadia Dreid ( August 16, 2019, 5:32 PM EDT) -- Glenmark Pharmaceuticals wants out of an antitrust suit tied to the cholesterol drug Zetia, telling a Virginia federal judge that new claims accusing it of working up a three-way conspiracy with two other drug companies to keep generic versions of the medication off the market are "implausible."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.